FDA Overstepped Authority on Whistleblower Surveillance
After several Food and Drug Administration employees exposed alleged flaws in the agency’s approval process for medical devices to Congress and the press in 2009, the FDA retaliated with a controversial email-monitoring program, sparking a lawsuit against the federal agency and ongoing questions about the legality and ethics of the surveillance. In January 2009, FDA…
